MSCG - Overview: Collagenofibrotic Glomerulopathy Confirmation, Mass Spectrometry
Aiding in the diagnosis of collagenofibrotic glomerulopathy
MSFNG - Overview: Fibronectin Glomerulopathy Confirmation, Mass Spectrometry
Aiding in the diagnosis of fibronectin glomerulopathy
Identification of breast and urinary cancer, among others
HPVLR - Overview: Human Papillomavirus (HPV) Low Risk, In Situ Hybridization
Detection of human papillomavirus from low-risk genotypes (6, 11)
HPVE6 - Overview: Human Papillomavirus (HPV) High-Risk E6/E7, RNA In Situ Hybridization
Stratification of oropharyngeal squamous cell carcinoma
23FBG - Overview: Fibroblast Growth Factor-23 (FGF23), In Situ Hybridization
Assessing fibroblast growth factor-23 (FGF23) expression
JCV - Overview: JC Virus Detection by In Situ Hybridization
Confirming a clinical and histopathologic diagnosis of progressive multifocal leukoencephalopathy
ALKLC - Overview: Anaplastic Lymphoma Kinase for Lung Cancer, Immunohistochemistry
Identification of anaplastic lymphoma kinase overexpression Diagnosis of inflammatory myofibroblastic tumor, anaplastic large-cell lymphoma, and for targeted therapy of lung adenocarcinoma
Diagnosis of small cell lung carcinoma (SCLC), large cell neuroendocrine carcinoma (LCNEC), amongst other tumors
HPVHL - Overview: Human Papillomavirus (HPV) High/Low Risk, In Situ Hybridization
Detecting human papillomavirus for both low-risk (6, 11) and high-risk (16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82.) genotypes